&nbsp;

Timely.png

Sep 2019

Tests de dépistage du cancer et confidentialité

Regimen

GEMC

Cancer Type:

Hematologic,

Lymphoma - T-cell,

Rare Diseases

Intent: Palliative

Drugs Used:

gemcitabine

... Show more tags

Quick Link(s):

Regimen Monograph

Sep 2019

Blog posts

Guidelines ensure consistent high-quality care across the province

Dr. Leta Forbes, Medical OncologistProvincial Head, Systemic Treatment ProgramOntario Health (Cancer Care Ontario) Reactions to the injection of...

Sep 2019

Regimen

GDP+OBIN

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma

ODB - General Benefit

dexamethasone

Drugs Used:

Quick Link(s):

Regimen Monograph

Mar 2020

Traitements systémiques pendant la pandémie de la COVID-19 : Ressources à l’intention des fournisseurs de soins de santé

Statistical Reports

Glossary

Document

GEMCNPAC(W).pdf

Dec 1969

Document

GEMCNPAC(W)-FR.pdf

Dec 1969

Document

tomMcHughProfile.png

Dec 1969

Regimen

GEMOD

Cancer Type:

Hematologic,

Lymphoma - T-cell

Intent: Adjuvant, Curative, Palliative

Funding:

ODB - General Benefit

dexamethasone

Drugs Used:

Quick Link(s):

Regimen Monograph

Regimen

GEMOX

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Palliative, Curative, Adjuvant

Drugs Used:

gemcitabine,

oxaliplatin

... Show more tags